Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Oligodendroglioma
• Astrocytoma
• Ependymoma
• Ganglioglioma
• Glioblastoma
• Malignant Glioma
• Oligodendroglioma
• Pilocytic Astrocytoma

Drugs mentioned

• rQNestin34.5v.2

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Malignant Glioma of Brain, Astrocytoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING